Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

Business - The New York Times - Yesterday

Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.

Business - MarketWatch - November 11

AbbVie shares tumble after schizophrenia drug disappoints

US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms

Business - Financial Times - November 11

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing ...

Business - MarketWatch - November 14

Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals

The biotech company said it will discontinue a second trial but will still offer a full analysis of the data.

Business - MarketWatch - Yesterday

AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say

AbbVie’s “pain” is Bristol Myers Squibb’s “gain,” says Truist Securities analyst Srikripa Devarakonda.

Business - MarketWatch - November 12

Chancellor and BoE governor call for UK to rebuild ties with EU

Reeves and Bailey highlight damage from Brexit amid concern about Trump’s plan to impose tariffs on trading partners

Business - Financial Times - November 14

Britain’s bold plan to create super funds

The case for consolidating the UK’s sprawling pension arsenal is strong

Business - Financial Times - November 14

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Novartis Lifts Guidance Again After Key Drugs Help Results

The pharmaceutical giant raised its full-year guidance for the third time this year after higher third-quarter profit and sales topped analysts’ expectations, boosted by revenue from its key drugs.

Business - The Wall Street Journal - October 29

Rapper Young Thug pleads guilty to gang, drug and gun charges almost a year after opening statements in trial

Entertainment - ABC News - October 31

Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.

Business - CNBC - October 30

European committee takes a second look at Alzheimer's drug and now says it should be approved

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug

Health - ABC News - November 14

US flights to Haiti halted for month after attacks

America's aviation regulator suspends US flights to the country after three gun attacks on planes.

'Never': Jimmy Lai denies foreign collusion in landmark trial

Lai, one of the most influential pro-democracy figures in Hong Kong, is accused of colluding with foreign forces.

Over 100 sentenced for drug-related crimes in Belgium’s largest trial

Decryption of Sky ECC messaging system leads to 119 convictions

World - Financial Times - October 29

An Australian on trial for drugs in Japan says she's the victim of a romance scam

An Australian accused of smuggling amphetamines in a suitcase has appeared in a Japanese court nearly two years after her arrest and said she was tricked into carrying them as part of an online ...

World - ABC News - November 18

A promising schizophrenia drug showed mixed results. What does that mean for patients?

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the research

Health - ABC News - October 31

'I didn’t think there was cause to shoot Chris Kaba' – police watchdog lead defends sending case to CPS

Sal Naseem tells the BBC he wasn't convinced Mr Kaba presented a sufficient danger to justify being shot.

Oil ends down on the day, up for the week on conflicting supply-demand prospects

Oil futures finished lower on Friday, with China’s latest round of stimulus measures failing to lift expectations for energy demand in the face of President-elect Donald Trump’s support for more ...

Business - MarketWatch - November 8

Mozambique’s Main Port Halts Taking Cargo After Election Unrest

World - Yahoo News - November 6

Idaho's plan to execute serial killer halted after botched attempt

Thomas Creech has been in prison for half a century, convicted of five murders in three states and suspected of several more.

Airlines halt flights to Haiti after plane hit by gunfire

Spirit Airlines flight heading from Florida to Port-au-Prince diverted to Dominican Republic after flight attendant was grazed by bullet, amid broader violence in Haiti’s capital. Haiti’s ...

World - The Guardian - November 12

U.S. airlines halt travel to Haiti after shots fired at planes

Major U.S. airlines have canceled trips to Haiti after two planes coming from Fort Lauderdale and New York were shot at. CBS News Miami's Tania Francois reports.

U.S. halts flights to Haiti after 3 planes hit by gunfire

U.S. airlines are barred from flying to Haiti for a month after 3 American carriers' planes are hit by gunfire amid relentless gang violence in the Caribbean nation.

Doctors Without Borders halts operations in Haiti's capital after escalation in violence

Doctors Without Borders said that it is stopping operations across Haiti's capital Port-au-Prince and due to an escalation in violence to its staff. from police.

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - October 30

Saquon Barkley didn't question controversial fumble that resulted in Jaguars TD: 'I knew it was gonna stand'

Barkley didn't question the ruling of the fumble

Sports - CBS Sports - November 4

Mike Tyson vs. Jake Paul undercard results: Katie Taylor gets controversial win to retain vs. Amanda Serrano

The rematch featured a fair share of headbutting and cuts on Friday night in Texas

Sports - CBS Sports - November 16

Pair sentenced for drug supply after teenager died

Lucy Hill, 16, died in December 2022 after taking MDMA and collapsing at a nightclub.

Dozens jailed in drug smuggling mega-trial: "Your honor, I played, I lost."

The multinational cocaine and cannabis trafficking enterprise was busted after investigators cracked encrypted messaging apps.

‘Was I drugged and raped? I’ll never know’: partners of accused share fears at Pelicot trial

Some ex-girlfriends of accused men tell court of burden of not knowing if they had been sedated and molested in past . Giving evidence in Avignon’s criminal court, a softly spoken woman in her 30s ...

World - The Guardian - November 8

Pelicot trial: young vineyard worker proposed drugging and raping his own mother

Video showed Charly A, one of 51 men accused of raping Gisèle Pelicot, discussing plan with Dominique Pelicot. A young vineyard worker accused of raping Gisèle Pelicot on six occasions over four ...

World - The Guardian - November 15

Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation

The news may help Merck retain sales of Keytruda, which is the world’s best-selling drug.

Business - MarketWatch - November 19

Microsoft's stock has worst day in two years after disappointing forecast

Microsoft's stock fell more than 6% on Thursday after guidance fell short of analysts' estimates.

Business - CNBC - October 31

Latest in Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results